Prevalence of High-risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results From NHANES 2017

Prevalence of High-risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results From NHANES 2017–2018

Published:2021-12 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Vilar-Gomez Eduardo,Vuppalanchi Raj^ORCID,Mladenovic Andrea,Samala Niharika,Gawrieh Samer,Newsome Phil N.,Chalasani Naga

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort;Harrison;J Hepatol,2021

2. Nonalcoholic fatty liver disease in Latinos;Saab;Clin Gastroenterol Hepatol,2016

3. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: results from NHANES 2017-2018;Zhang;PLoS One,2021

4. Non-alcoholic fatty liver disease - a global public health perspective;Younossi;J Hepatol,2019

5. NASH is the most rapidly growing etiology for acute-on-chronic liver failure-related hospitalization and disease burden in the United States: a population-based study;Axley;Liver Transpl,2019

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic characteristics of patients with MetALD: Caveats of a new definition;Liver International;2024-08-17

2. Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics;Clinics and Research in Hepatology and Gastroenterology;2024-08

3. Genotype-by-Environment Interactions in Nonalcoholic Fatty Liver Disease and Chronic Illness among Mexican Americans: The Role of Acculturation Stress;Genes;2024-08-01

4. Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysis;Clinical Gastroenterology and Hepatology;2024-07

5. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease;Journal of Hepatology;2024-07